Telus Ventures adds three Canadian precision medicine, diagnostics startups

VANCOUVER - Telus’ strategic investment arm Telus Ventures has added three early stage precision medicine and diagnostics-focused Canadian startups to its portfolio of health technologies.Toronto-based Acorn Biolabs, Vancouver’s GenXys Health Systems and Vital Biosciences join Telus Ventures’ other active investment companies, and build on the more than 70 transactions made since 2001 to deliver on a commitment to help develop exciting, new health technologies with the potential to improve the health outcomes of patients across Canada and worldwide through the delivery of customized and timely patient care.Telus Ventures said that the market for precision medicine and diagnostics is poised for...